What Can We Expect After Essilor International (EPA:EI)’s Upgrade By Morgan Stanley?


Essilor International (EPA:EI) Stock Upgrade

Essilor International (EPA:EI)’s stock was raised to a solid “Equal-Weight” by stock analysts at Morgan Stanley. EI’s past “Underweight” rating is has been discontinued by the brokerage firm.

From a total of 5 analysts covering Essilor International (EPA:EI) stock, 2 rate it a ”Buy”, 0 a “Sell”, and 3 a ”Hold”. This means that 40% of the ratings are positive. The highest target price is €135 while the lowest target price is €79. The mean of all analyst targets is €116 with a -1.19% below today’s (€117.4) stock price. Essilor International was the topic of 8 analyst reports since July 24, 2015 according to the firm StockzIntelligence Inc. Morgan Stanley upgraded shares on December 8 to “Equal-Weight” rating. Morgan Stanley downgraded shares to “Underweight” rating and €104 target share price in a report from an October 22. JP Morgan maintained EI stock in a recent report from October 23 with “Neutral” rating. Finally, Societe Generale downgraded the stock to “Buy” rating in a report issued on a July 31.

Approximately 184,257 shares of stock traded hands. Essilor International Cmpgn Gnl d’Opq SA (EPA:EI) has 0.00% since May 12, 2015 and is . It has outperformed by 0.80% the S&P500.

 What Can We Expect After Essilor International (EPA:EI)'s Upgrade By Morgan Stanley?

Essilor International SA is an ophthalmic optics company. The company has a market cap of 25.92 billion EUR. The Firm also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals. It has 41.01 P/E ratio. The Firm operates through three divisions: Lenses and Optical Instruments, Equipment and Sunglasses & Readers.